相关实验视频
Updated: Jun 12, 2025
05:51
Characterization of a Novel Human Organotypic Retinal Culture Technique
Published on: June 9, 2021
3.9K
整合素在糖尿病视网膜病变中的治疗潜力
Li-Mei He1, Sarul Borjigin2, Xin-Qi Chen1
1Department of Internal Medicine, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China.
World journal of diabetes
|June 9, 2025
概括
综合素在糖尿病视网膜病变 (DR) 的发展中起着关键作用. 向整合素显示出新的DR治疗方法的希望,为预防视力损失提供了希望.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病视网膜病变 (DR) 是由于糖尿病引起的高血糖症导致视力丧失的主要原因.
- 整体素在DR病变发生过程中至关重要,调解炎症,血管泄漏,微血栓形成和血管生成.
研究的目的:
- 审查整合素在DR病变发生过程中的作用.
- 评估整合素抗剂作为DR的潜在治疗点.
主要方法:
- 关于DR中整合素功能研究的文献综述.
- 对整合素抗剂治疗的临床试验结果的摘要.
主要成果:
- 综合素通过各种分子机制显著促进DR的进展.
- 整合素抗剂的临床研究表明有效性,但也带来了挑战.
结论:
- 向整合素代表了糖尿病视网膜病变的一种有前途的治疗策略.
- 需要进一步的研究来克服挑战,并优化对DR的整合素抗剂疗法.
相关概念视频
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:23Dipeptidyl Peptidase 4 Inhibitors
177
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
177